Zimmer Biomet Holdings ZBH
$101.10 −$0.37 (-0.36%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $100.82 -0.28%
Open$102.72
Prev close$101.47
Day range$100.82 – $103.87
Volume2.96M
Market cap$19.13B
P/E (TTM)25.5
Dividend yield0.95%
ZBH Stock News
Headlines matching Zimmer Biomet Holdings or the ZBH ticker, most recent first.
- Truist Financial Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating
- BofA Securities Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Maintains Target Price $110
- Truist Financial Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Announces Target Price $106
- A Quick Look at Today's Ratings for Zimmer Biomet Holdings(ZBH.US), With a Forecast Between $99 to $120
- J.P. Morgan Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Raises Target Price to $117 Positive
- Analysts Conflicted on These Healthcare Names: ArriVent BioPharma, Inc. (AVBP), Zimmer Biomet Holdings (ZBH) and Tecan Group AG (OtherTCHBF)
- Citi Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Maintains Target Price $99
- Analysts' Opinions Are Mixed on These Healthcare Stocks: CG Oncology, Inc. (CGON) and Zimmer Biomet Holdings (ZBH)
- Truist Financial Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Maintains Target Price $106
- BofA Securities Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Raises Target Price to $110 Positive
- CCORF Upgrades Zimmer Biomet Holdings(ZBH.US) to Buy Rating, Raises Target Price to $100 Positive
- Citi Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Maintains Target Price $93
- Evercore Maintains Zimmer Biomet Holdings(ZBH.US) With Buy Rating, Cuts Target Price to $110 Negative
- UBS Upgrades Zimmer Biomet Holdings(ZBH.US) to Buy Rating, Raises Target Price to $115 Positive
- BTIG Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating
No comments yet — be the first to weigh in on ZBH.
Sign in to join the discussion.